Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby dorosłe mówiące po angielsku (powyżej 18. roku życia).
- •Minęło co najmniej 6 miesięcy od diagnozy chłoniaka i nie minęły więcej niż 2 lata od zakończenia aktywnego, leczącego leczenia (jak operacja, chemioterapia, radioterapia lub inne).
✗ Disqualifies
- •Obecne problemy ze zdrowiem psychicznym lub trudności z myśleniem, które uniemożliwiają udział (ocenione przez lekarza).
- •Niechęć lub niemożność uczestniczenia w spotkaniach online (przez internet).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 9, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Mass General Brigham
Boston, United States
Trial contact
Giselle Perez, PhD
Giselle Perez, PhD
PRINCIPAL_INVESTIGATOR
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.